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Objectives. This study analyzed the Immediate and loatterm
outcome of percutaneous balloon attend vilrotmay, In patients
with and without Omoroscopially visible mitral valve calcification.
Background. Mural vain calcification has have shown to bean
Important factor In determining Immediate mad bug-term out
.
came of patients undergoing surgical mural comma s uolmay .
Patient selection has an Important import on the outcome of
pereuls"em balloon mitral valvobmy .
Methods. The Immediate and long-tin resuhsof perataxmu
balloon mitral valvotmty were compred in 155 patients with and
173 patients without mitral valve calcification . The patients with
calcified valves were assigned to four groups according to severity
of calcification.
Resela
.
Patients with calcified mltrd steosb more fregmntly
were b New York Heave Association fcnctlonal dam fff or IV and
more frequently had afrW fibrillation, previous surgical commie .
surotomy, echoardtographk score >8, higher pulmonary artery
and left atrtal pressures, higher pulmonary vascular resistance
and mean mitral valve gradient and lower cardiac output and
smaller mitral valve
am .
Mitres valve am after vdvatomy was
significantly smaller In patients with calcified valves (1 .8 t 0 .06
Perutaneous mitral balloon valvotomy is an alternative to
surgical treatment for symptomatic mitral stenosis . Patient
selection has an important impact on the outcome of percu-
taneous mitral balloon valvotomy (1,2) . We have shown that
echocardiography helps in decision making before mitral
valvotomy by using a morphologic "scoring"
of the mitral
valve (3) . Before the era
of
open heart surgery, calcification
of the mitral valve was considered to be an important factor
in determining the immediate outcome of patients under-
going surgical closed commissurotomy (4,5) . Calcification
of
the mitral valve decreases the chances of favorable immedi-
ate outcome and long-term event-free survival after surgical
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.1 t 0 .06 ®') and wss z1 .5 cm' fn 65% otpatients with lad
83% of patients without calcified valves (p = 0 .004). A successful
outcome, defined as mitrd valve area >1 .5 cm' without slgalfcant
tai al regurgitation and left to right shunting, was achieved in
52% of patients with and 69% of patients without anakited
valves (p = 0 .001). The success rah was 59%, 48%, 35% and
33% is
subgroups
with 1+, 2+, 3+ and 4+ akifatMo, respec.
lively. The rates of sfgnifaet kit to right shaft and mitral
regnrgftMioa after vdvabplasty were similar he the two groups .
Estimated survival ate (M% vs. 99%, respectively, p = 0.0001),
survival rate without mitral valve repiaawnt (67% vs
. 93%,
respectively, p < 0.08005) and event-free survival rate (63% vs .
88%, respectively, p < 0.80085) at 2 years wee sigdfeaofy
better lit The patients with anealdfed salve. Survival rate carve
became progressively worse as the severity of caldfcatlon
increased .
Comdnuoae. These fadfap hdkate that Immediate nd long-
term results of mifnl valvalophsty are ant s swccemfd la
pdkatsw th 6macopienfy vi ible mitral valve salcificatbe s Y
dim without aacYadaa,
(J Am Col Cordial 1994;23:1604-9)
commissurotomy (2,6). Furthermore, we have found that the
absence of calcium visible under fluoroscopy is an indepen-
dent predictor of event-free survival after percutaneous
mitral balloon valvotomy (2). Thus, this study was under.
taken to evaluate the effect of fluoroscopic calcification of
the mitral valve on the immediate and long-term outcome of
percutaneous mitral balloon valvotomy .
Methods
Study patients
. The study group included 328 (267 women,
61 men; mean [=SEM] age 54 = I years) consecutive patients
who underwent percutaneous mitral balloon valvotomy at
the Massachusetts General Hospital between August 1986
and September 1989 . Of these 328 patients . 155 had fluoro.
scopically visible calcium involving the mitral valve lesilets .
The remaining group included 173 patients who did not have
fluorescopically visible mitral valve calcification .
All patients were screened clinically and by echocardiog-
raphy. Transesophageal echocardiography was used rou-
tinely in patients with a suboptimal transthoracic study or a
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history of a previous embolic event or possible left atrial
thrombus. Patients with left atrial thrombus, atria) fibrilla-
tion or history of thromboembolism received anticoagulation
with warfarin for 2 to 3 months before a second evaluation .
Procedure . After right and left heart catheterization,
transseptal left heart catheterization and hemodynamic mea-
surements, percutaneous mitral balloon valvotomy was per-
formed as previously described (7) . The single-balloon tech-
nique was used in 25 patients in the earlier part of our
experience and the double-balloon technique in the remain-
ing patients (7) . Oxygen saturation of blood samples from the
superior versa cava, pulmonary artery and aorta were deter-
mined before and after valvuloplasty . When there was
evidence of left to right shunting (?7% step-up in oxygen
saturation measurements between the right atrium and pul-
monary artery), or when significant tricuspid regurgitation
was present by physical examination or echocardiography,
or both, cardiac output was calculated according to the Fick
principle rather than by thermodilution . In the presence of
left to right shunting, the oxygen content of a blood sample
from the superior vena cava was used as the mixed venous
blood sample . Oxygen consumption was measured by an
MRM-2 oxygen consumption monitor (Waters Instrument
Inc.) . A left ventriculogram was performed in the right
anterior oblique projection before and after mitral valvotomy
to assess severity of mitral regurgitation .
Data collection . The following variables were prospec-
tively entered into the computerized data base
: demographic
variables-age, gender, body surface area ; clinical variables-
functional class, presence of atrial fibrillation, previous surgical
commissurotomy ; laboratory variables-echocardiographic
score
(3), severity of
mitral regurgitation as graded according
to the Sellers classification using contrast left ventriculogra-
phy
(8),
iluoroscopieally visible mitral valve calcification
graded from 0 to 4+ (0 = no, l+ = mild, 4+ = severe
calcification) (7); hemodynamic variables before and after
percutaneous mitral balloon valvotomy--mean pulmonary
artery and left atria] pressures, pulmonary vascular resis-
tance, mean mitral valve gradient, cardiac output and calcu-
lated mitral valve area .
To assess the interobserver variability in determining the
severity of valvular calcification according to the semiquan-
titative (0 to 4+) grading system, 50 randomly selected
cineangiograms were examined by two independent physi-
cians. There was complete agreement in the grading of
calcification in 42 of the 50 cases . Agreement was not
present In eight cases, but the disagreement was not by more
than one grade in any of the cineangiograms . The first
observer graded three cases as 3+ and two cases as I+,
whereas the second observer graded them 2+ and 0+,
respectively . The first observer graded one case 2+, one
case 1+ and one case 0+, whereas the second observer
graded them 1+, 2+ and
0+,
respectively. The interobserver
variability was determined using the kappa statistic
; kappa
was calculated as 0 .73, representing excellent agreement
between the observers (p < 0.001).
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Follow-up.
Patients were interviewed by telephone every
6 months. When necessary, local physicians were contacted
for further information or records . Follow-up information
included survival status, mitral valve replacement, and clin-
ical status represented by functional class. The mean follow-
up period was 20 t I months.
Method of analysts, Patients with mitral valve calcifica-
tion were assigned to four subgroups according to the
severity of calcification (1+, 2+, 3+, 4+, respectively) .
Successful outcome was defined as a final mitre) valve area
?l
.5 cm` without a w2+ increase in mitral regurgitation and
without a left to right shunt with a pulmonarylsystemic ratio
of X 1 .5 :1 after valvuloplasty. Procedure-related death was
defined as in-hospital deaths that were directly or indirectly
caused by valvuloplasty . In-hospital deaths that clearly had
unrelated causes were not considered procedure-related
deaths . The following complications of mitral valvuloplasty
were analyzed : pericardial tamponade, thromboembolism,
high grade atrioventricrdar block, ~2+ Initial regurgitation and
left to right shunt with a
pulmonary/systemic
ratio a 1.5 :1 .
Statistical analyses were carried out with the use of the
BMDP statistical package (Release 7 of 1992 from BMDP
Statistical Software, Inc .) . Continuous variables were com-
pared with one-way analysis of variance followed by inter-
group comparison corrected for multiple comparisons by the
Bonferroni theorem, an option in the BMDP program. A p
value of <0 .05 was used as the minimal value for statistical
significance. Values are expressed as mean values ± 1 SEM .
The interobserver variability was determined using the
kappa statistic (9) . The time-related events noted during
follow-up were examined using the Cox model (10) . Actuar-
ial survivorship, actuarial survivorship with freedom from
mitral valve replacement and functional class Ili or IV were
analyzed . Estimated survival curves with the Cox model
were constructed for patients with no calcification and for
those with 1+, 2+, 3+ and 4+ calcification
.
Results
Baseline variables . Baseline characteristics of the pa-
tients are shown in Table I . Patients with calcified valves
were significantly older than those free of calr lications (6t t
I vs
. 47 t 1, respectively, p < 0 .0X001) . There was a positive
correlation between severity of calcification and patient age
(p < 0
.005, r = 0.46)
. Significantly more patients were In
functional class III or IV in the group with (85%) than
without (65%) calcifications (p < 0 .00001) . Atrial fibrillation
and history of previous commiseurotomy vere also more
common in the group with than without calcifications (640
vs . 35%, p < 0.0001 ; 29% vs . 13%, p = 0
.005, respectively)
.
Mean echocardiographic score and percent of patients with
an
echocadiogtaphic score >8 were significatly higher among
patients with than without calcifications (8 .9 t 0.2 vs. 6 .3
0.1, p < 0.00001 ; 60%0 vs . 13%, p < 0.0000 1 . respectively) .
Hemodynamic variables
. Hemodynanlic findings before
and after mitral valvotomy are shown in Table 2 . Mean
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Tattle 1. Baseline Clinical Characteristics of Patients With and Without Calcified Mitral Valves
Pls With Cakficalions
Pis Without
Calcdoations All Pls 1+ 2+ 3+ 4+
Data presented are mean values ± SD or number (%) of patients (P15) . Echo = echocardiogaphic; F = female ; M = male ; NYHA = New Ymk Heart
Association' I+ to 4+ = grade of calcification .
mitral gradient and left atrial pressure were similar in the two
groups before valvuloplasly but were significantly higher in
the grWp with than without calcifications after valvuloplasly
(6 t 0 .2 vs . 5 ± 0.2 mm Hg, respectively, p = 0 .007) . Mean
pulmonar,' artery pressure before and after valvuloplasty
was higher in the group with than without calcifications
(41±2vs.35Y1,It=0.0001 ;33 ±1vs .27±IminHg,p<
0 .00001, respectively) . Mean left atrial pressure was similar
in the two groups before valvuloplasty but was higher in the
group with than without calcifications after valvuloplasty
(25±Ivs.24±5,p=N5 ;17±Ivs.IS±ImmHg,p=
0 .0002, respectively). Mean mitral valve area before and
after valvuloplasty was smaller among patients with than
without calcifications (0 .8 A 0 .2 vs. 0.9 ± 0 .2, p = 0.004 ;
1.8 ± 0 .6 vs. 2.1 ± 0 .6 cm', p = 0.0002, respectively) .
Cardiac output before and after valvuloplasty was lower in
the group with than without calcifications (3 .7 ± 0.1 vs.
4 .1 s 0 .1, p = 0.001 ; 4 .3 ± 0.1 vs . 4 .6 ± 0.1 Bterslrain, p =
0 .003, respectively). Pulmonary vascular resistance before and
after valvuloplasly, was higher in the group with than without
calcifications (416 ± 32 vs . 247 ± 17, p < 0.00001 ; 321 ± 21
vs. 222'_ 11 dynes-s-'-cm-', p < 0 .00001, respectively) .
Immediate oueome and eemplleadow . A final mitral
valve area al .5 can" was achieved in 101(65%) patients with
Table 2. Hemodynamic Findings Before and After Must Valvuloplasty in Patients With and
Without Calcified Valves
Pls With Calc&-Adms
Pis Without
Calcifications All Pis 1+ 2+ 3+ 4+
Data presented are mean vsiues ± SD . CO -cardiac mLAP = mesa left atria) pessure (mm
Hg); mOAP = mean pulmonary artery pressure (mm Hg) ; MVA= mitral valve area(cmr) ; MOD - menu mitid valve
gradient (mm Hg) ; Pre (PosI)PMV = before (aher) pereutarxous balloon initial valvotomy ; PVR = pulmonary
vascular resistance (dynes-rum t) ; other abbreviations and symbols ss in Table 1 .
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Age (yr) 47±1 61**-1 5932 61*_2 67x3 73±3
F1M 143130 124131 60'15 43111 1413 72
NYHA class
1 614%) 1 (1%) 00%) 1(2%) 000%) 00%)
11 54(31%) 23(15%) 10(13%) 10(10 2 (12%) 1(11%)
III 103(60%) 89(57%) 50(67%) 30(56%) 7(41%) 2(22%)
IV 9(5%) 42(27%) IS (20%) 13(24%) 8(47%I 6(67%)
Alual fibrillation 60(35%) 99(64%) 53(71%) 30(56%) 11(65%) 5(56%)
Previouscomoisurmomy 23(13%) 44(29%) 24(32%) 13(24%) 5(29%) 2(22%)
Echoscore 6.8±0.1 8.9±0.2 8.130.2 9.2±0 .3 10.730.6 10.830.6
>8 22(13%) 93(60%) 3507%) 36(67%) 13(77%) 9000%)
mPAP
Pro.PMV 35x1 4131 41±2 40±2 48±3 42±5
PosI-PMV 27±1 33±1 32±1 32±2 37±4 42±5
oLAP
Pro-PMV 24±1 2531 24±1 25±1 28±2 25±2
Pust.PMV 15±1 17±1 17x1 1731 1832 2133
MVG
Pre-PMV 1531 1531 14*_1 1531 1731 17!2
Post-PMV 3±0.2 6±0.2 5x0 .3 630.4 730.7 731
CO
Pre-PMV 4.136.1 3 .7 ± 0.1 3.8±0 .1 3.3x0.1 3.630.3 3 .7x0.3
Post.PMV 4.6±0 .1 4 .3±0.1 4.3±0.1 4.3±0.2 4.3±0.4 4 .2±0.5
MVA
PraPMV 0.9±0 .02 0.8±0.02 0 .9±0.03 0.8±0.04 0.6±0.01 03±0.07
Post-PMV 2 .1±0.06 1 .8±0.36 2 .0±0.08 1.7±0 .01 13x0.02 1 .4±0.1
PVR
Pre-PMV 247 ± 17 416 3 32 434 ± 53 378 ± 40 487 ± 84 351 ± 68
Post-PMV 222 x 1I 321 ± 21 307 2 28 344 ± 43 365 ± 46 153 ± 37
IACC Vol
. 23
. No
. 7
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Figare 1 . Estimated survival rate at 2 years after
percutaoeous nlitral valvotomy, stratified by
sever-
ity of calcification . Ca r to Cai4 = calcification
grades ; No Ca = no calcifications.
and l44 (83%) without calcifications (p = 0
.004)
. Of the
patients who hid a final mitral valve area >_ 1 .5 cm'-, a a2+
increase in mitral regurgitation occurred in I I patients with
and 12 patients without calcifications, and a 0_1 .5:1 left to
right shunt was detected in 7 patients with and 11 patients
without calcifications. Thus, a successful immediate out-
come was achieved in 80 (52%) patients with and 120 (69%)
patients without calcifications (p = 0 .001) . The success rate
was 59%, 48%, 35% and 33% in the
I+, 2+, 3+ and 4+
subgroups. respectively.
There were three procedure-related deaths in the group
with calcifications: One patient in cardiogenic shock who
had emergency percutaneous mitral balloon valvotomy died
despite a technically successful and uncomplicated proce-
dure ; one patient died of left ventricular perforation and
cardiac tamponade; and one patient died of intractable right
ventricular failure during emergency mitral valve replace-
ment. All deaths occurred early in our experience .
There
were no deaths in our last 200 patients
.
Mid regargitath. Before percutaneous mural balloon
valvotomy, 76 (49%) patients with calcifications had a mitral
regurgitation score of 1+ (63 patients) or 2+ (13 patients),
and 42 (24%) patients without calcifications all had a score of
I + (p < 0.0001)
. Increase in mitral regurgitation
was similar
in both groups (60 patients [39%] with, 69 patients [40%]
without calcifications, p = NS). At.. increase a2+ occurred
in 17 patients (11%) with and 16 patients (9%a) without
calcifications (p = N3) .
Lalt to right shun.ne. A step-up between the oxygen
saturations of right alrial and pulmonary artery blood sam-
ples a7% was detected in 27 patients (17%) with versus 24
patients (15%) without calcifications (p = NS) . A left to right
shunt with a pulmonary/systemic flow ratio ml .5:1 was
detected after percutaneous mitral balloon
valvotomy in 17
patients (l!%) with versus 15 patients (9%) without calcifi-
cations (p = NS) .
Follow-up. In addition to three procedure-related deaths
there were 22 late deaths, 21 in patients with and 1 in patients
without calcifications . The estimated survival rare at 2 years
TUZCU ET AL.
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MONTHS
was significantly lower in patients with than without calcifi-
cations (80% vs
. 99%, respectively, p = 0
.1001) (Fig. 1) . The
estimated survival rate at 2 years in patients with calcifica-
tions became significantly poorer as the severity of calcifi-
cation increased (p < 0.00005) (Fig . 1).
During the follow-up period, 31 patients underwent mitral
valve replacement (2! patients with, 10 patients without
calcifications). The estimated survival rate with freedom
from initial valve replacement at 2 years was significantly
lower in patients with than without calcifications) (67% vs.
93%, respectively, p < 0.00005) (Fig. 2) . The estimated
survival rate with freedom from mitral valve replacement at
2 years in patients with calcifications became significantly
poorer as the severity of calcification increased (p < 0 .05)
(Fig. 2) .
At the time of last follow-up contact, 76 patients with
calcifications were in functional class 1, 28 in class ll, 8 in
class Ill and none in class IV
;122 patients with calcifications
were in functional class 1, 26 in class 11, 7 in class Ill and I
in class IV. The estimated survival rate with freedom from
initial valve replacement and functional class III or IV at 2
years was significantly lower for patients with than without
calcifications (63% vs. 88%, respectively, p <
0.00005)
. The
actuarial survival rate with freedom from mitral valve re-
placement and functional class III or IV at 2 years in patients
with calcifications became significantly poorer as the sever-
ity of calcification increased (p < 0 .00005) .
Discussion
hlltral valve calcification and immediate outcome of percu-
tarceous mttral valvutoplesty . Our study demonstrates that
the presence of fluoroscopically visible calcification on the
mitral valve influences the success of percutaneous mitral
valvuloplasty. The immediate and long-term outcome of
percutaneous mitral balloon valvotomy in this study shows
the importance of carefully evaluating the degree of mitral
valve calcification by fluoroscopy to identify patients with
mitral stenosis who are less likely to have a good
outcome
1607
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with mitral valvotomy . Although the amount of calcification
does not affect procedural mortality or complications, pa-
tients with heavily (3+, 4+) calcified valves have a poorer
immediate outcome than those with uncalcifed valves, as
reflected in a smaller mitral valve area and greater mitral
valve gradient after percutaneous mitral balloon valvotomy
.
Immediate outcome is progressively worse as the calcifica-
tion becomes more severe . Our findings are in agreement
with those in previously reported studies . In the early years
of closed commissurotomy, inadequate opening of the valve
and early recurrence of
symptoms were noted in patients
with palpable calcium on the mitral valve (6) .
Radiologically
visible mitral valve calcification was also found to be an
adverse factor in surgically closed ntitral commissurotomy
,
(11) . With open commissurotomy, mildly calcified valves
can be successfully treated by commissmntomy, but heavily
calcified valves are best treated by mitral valve replacement
(12).
In this study, in contrast to poorer immediate hemody-
nomic outcome. the impact of
calcification on procedural
mortality and complications was not significant . There were
no significant differences in postvalvuloplasty mitral regur-
gitation., left to right shunting Or procedure-related mortality
between the two groups .
The factors that predict mitral regurgitation after percu-
taneous mitral balloon valvotomy are controversial . Abascal
et al. (13), in a relatively small study, showed that valvular
anatomy is not a predictor of significant mitral regurgitation
after mitral valvotomy. Roth et al. (14) reported that balloon
size was the only predictor of significant Initial regurgitation
after percutaneous mitral balloon valvotomy . Others (15)
have shown the importance of the severity of valvular and
subvalvular disease. In this study, patients with heavily
calcified valves are not more likely to have mitral regurgita-
tion than those with no or mild calcification . Sancho et al.
(16) reported similar findings showing no relation between
valvular calcification and mitral regurgitation after percuta-
neous mitral balloon valvotomy . Although our data suggest
that patients with heavily calcified valves do not have a
higher risk for developing significant mitral regurgitation,
JACC VoL 2+, No . 7
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Figure 2. Estimated survival rate at 2 years with
freedom from mitral valve replacement after percuta-
neous mitral balloon vatvotomy, stratified by severity
of calcification. Abbreviations as in Figure 1.
this cannot be taken as conclusive evidence because of the
relatively small number of patients with heavily calcified
valves and the low incidence of
mitral regurgitation after
percutaneous mitral balloon valvotomy in our study .
Mkral valve calcfswtIon and long-tem follow-up at
perer mitral valvalopl sty. Mitral valve calcification
also has a significant negative impact on the clinical follow-up
of patients undergoing percutaneous mitral balloon valvot-
any . Patients with calcified mitral valves have a lower
survival Fate, lower survival with freedom from mitral valve
replacement and lower survival with freedom from both
mitral valve replacement and functional class III or IV than
patients with uncalcified valves. The results are worse as the
severity of mitral valve calcification increases . For example,
of patients with 3+ or4+ mitral valve calcification, only 40%
and 20%, respectively, were alive and free of mitral valve
replacement at 2 years . In contrast, of patients without
calcification, 85% were estimated to be alive, free of mitral
valve replacement and in a functional class <HI or IV at 2
years . These results are in agreement with several follow-up
studies of surgical mitred commissurotomy, that have shown
that patients with calcified mitral valves had a significantly
poorer survival rate than patients free of calcification
(17,18).
Our study seems to indicate that it is wise not to advocate
percutaneous mitral balloon valvotomy as the procedure of
choice in patients with heavily catdned mitral valves be.
cause of the poor immediate and long-term results of the
procedure. However, in the present audy 25%
of patients
with 3+ calcification were alive, free of mitral valve replace-
ment and in a functional class <111 at 2-year follow-up . This
percent should not be ignored because percutaneous mitral
balloon valvotomy can markedly reduce a patient's physical
and economic burdens compared with surgical treatment .
What differentiates this 25% of patients with 3+ calcification
who are good candidates for percutaneous mitral balloon
valvotomy from the remaining 75% who are unfavorable
candidates for this procedure is unknown . Although surgical
treatment could be a better option for those patients with
mitral stenosis and heavily calcified valves, percutaneous
IACC Vol. 23, No. 7
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mitral balloon valvotomy may be of use as a palliative
procedure in those patients who are not surgical candidates
because of associated major comorbid conditions .
Study limitations. Even though grading
of mitral valve
calcification was done by two of the investigators according
to the same criteria, it wad still an arbitrary classification .
The semiquantitative grading of calcification may be a
source of error. Cardiac output measurements were gener-
ally made by the thermodilution technique unless there was
evidence of left to right shunt detected by oximetry . Shouts
that were too small to be detected
by oximetry were un-
doubtedly present in some patients. The presence
of the
shunts might have affected calculation of final mitral valve
area ; however, it is unlikely that these alterations had a
major impact on the outcome of this study .
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